Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV
Release Date:
Interview with Michael T. Lu, MD, MPH, author of Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial, and Matthew J. Feinstein, MD, MSc, author of Statins, Inflammation, and Tissue Context in REPRIEVE. Hosted by Robert Bonow, MD. Related Content: Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV Statins, Inflammation, and Tissue Context in REPRIEVE
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV